Silihan lan utang jangka dawa perusahaan Acasti Pharma Inc. (ACST)

The asset value of Acasti Pharma (ACST) tracked on this chart stands at 0.00, while the market potential for therapeutic agents to combat neurological and skin pain remains significant. The business relies on creating new modifications of familiar compounds to improve their bioavailability in treating rare pathologies. The company's prospects are based on developing unique delivery methods for small molecules in cardiology.

Developing drug delivery systems for neurological pain requires significant capital to conduct late-stage clinical trials. By analyzing the corporation's long-term loans and borrowings, an investor assesses the total liabilities with a maturity of more than one year. This metric measures the long-term debt load, allowing for the determination of default risk in a rising rate environment. A stable debt level confirms the financial stability of Acasti Pharma (ACST). The current liquidity reserve minimizes dependence on external borrowings.